SinoFresh HealthCare Message to Shareholders Regarding April 5, 2011 SEC Ordered Temporary Trading Suspension

VENICE, Fla.--()--SinoFresh® HealthCare, Inc., (PINKSHEETS: SFSH.PK) announces that yesterday the SEC, by order, imposed a temporary suspension in the trading of the company stock. The order imposes a suspension period from 9:30 a.m. EDT on April 5, 2011, through 11:59 p.m. EDT on April 18, 2011. The Company respects the intent of the Securities and Exchange Commission (SEC) to require current information and filings for the benefit of the shareholders and the public at large.

The Company has been actively engaged for a number of weeks in the auditing process and has retained appropriate accounting professionals to complete audits and bring all filings current. The Company remains committed to this requirement and course and intends to complete the auditing and filing processes as expeditiously as possible.

David R. Olund, CEO states, "Senior Management remains focused and committed to the redevelopment plans that have been made public in recent weeks through our Press Releases. While we regret the current actions by the SEC we respect their intent and will comply with all necessary requirements while at the same time maintaining our focus on corporate redevelopment plans that we feel are in the best interest of our shareholders. We have great products, a great team and will continue to execute on our strategic plan as we proceed through the audit process. We will continue to report to our shareholders on our corporate progress as is deemed appropriate and prudent."

SinoFresh HealthCare, Inc. is a publicly traded company (PINKSHEETS:SFSH.PK) based in Venice, Florida, that manufactures and distributes nasal, oral and topical antiseptic germ-killing products. SinoFresh products are marketed and distributed globally through a network of strategic wholesale and retail partners. SinoFresh Healthcare, Inc’s, premier product, SinoFresh Antiseptic Homeopathic Nasal spray has in laboratory tests shown effective antiseptic capability against a variety of pathogens such as MRSA, E-Coli, H1N1 and a broad range of other viruses, molds, fungi and bacteria.

This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters. Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will likely result”, “outlook”, “project” and other words and expressions of similar meaning. No assurance can be given that the results in any forward-looking statements will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.

Contacts

SinoFresh HealthCare, Inc.
Dave Olund
941-375-8174 option 8

Sharing

Contacts

SinoFresh HealthCare, Inc.
Dave Olund
941-375-8174 option 8